IP Library › Granted Patent US 10,588,832
Granted Patent B2
US 10,588,832 · App. 15/856,190 · Granted Mar 17, 2020

Foamable sunscreen formulation

Inventors: David J. Milora (Blue Bell, PA); Harry Fallick (Wayne, PA)
Assignee: FALLIEN COSMECEUTICALS, LTD.
A61K8/046A61K8/0241A61K8/19A61K8/27A61K8/29A61K8/37A61K8/375A61K8/4993A61K8/60A61K8/731A61K8/8147A61K8/8152A61K8/8176A61K8/85A61K8/86A61K8/87A61Q17/04A61K2800/21A61K2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,588,832
App. No.
15/856,190
Granted
Mar 17, 2020
Kind
B2
Abstract

The present application relates to sunscreen formulations, including foamable sunscreen formulations, that comprise zinc oxide and titanium dioxide particles, suitably in the size range of about 1-100 nm. The compositions suitably produce a minimal residual whitening effect when applied to a skin surface.

Claims (52)

1. A foamable sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % titanium dioxide particles having a primary particle size of about 10 nm to about 500 nm;

b. about 0.1 wt % to about 10 wt % emulsion stabilizer;

c. about 0.1 wt % to about 25 wt % skin conditioner;

d. about 1 wt % to about 10 wt % emulsifier;

e. about 0.1 wt % to about 10 wt % suspending agent; and

f. the remainder water, wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

2. The foamable sunscreen formulation of claim 1 , wherein the wt % of titanium dioxide particles is about 1 wt % to about 10 wt %.

3. The foamable sunscreen formulation of claim 1 , wherein the titanium dioxide particles have a primary particle size of about 10 nm to about 200 nm.

4. The foamable sunscreen formulation of claim 1 , wherein the emulsion stabilizer is selected from the group consisting of microcrystalline cellulose, cellulose gum, xanthan gum, magnesium aluminum silicate and combinations thereof.

5. The foamable sunscreen formulation of claim 1 , wherein the skin conditioner is selected from the group consisting of C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, fatty acid esters of C 8 or greater and combinations thereof.

6. The foamable sunscreen formulation of claim 1 , wherein the emulsifier is selected from the group consisting of glyceryl stearate, ceteareth-20, polysorbate 80, and combinations thereof.

7. The foamable sunscreen formulation of claim 1 , wherein the suspending agent is selected from the group consisting of polyhydroxystearic acid, methyl methacrylate crosspolymer and combinations thereof.

8. The foamable sunscreen formulation of claim 1 , further comprising about 0.5 wt % to about 3 wt % film former, wherein the film former is selected from the group consisting of polyurethane-2, polymethyl methacrylate, tricontanyl poly(vinyl pyrollidone) (PVP), VP/eicosene copolymer, Alkyl Acrylate/methacrylate copolymer, Acrylates C12-22 Alkyl methacrylate copolymer and combinations thereof.

9. The foamable sunscreen formulation of claim 1 , further consisting essentially of about 0.01 wt % to about 1 wt % iron oxide particles.

10. A sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % active particles having a primary particle size of about 10 nm to about 500 nm;

b. about 0.1 wt % to about 10 wt % emulsion stabilizer;

c. about 0.1 wt % to about 25 wt % skin conditioner;

d. about 1 wt % to about 10 wt % emulsifier;

e. about 0.1 wt % to about 10 wt % suspending agent;

f. optionally about 0.01 wt % to about 0.1 wt % iron oxide particles; and

g. the remainder water, wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

11. The sunscreen formulation of claim 10 , wherein the wt % of active particles is about 1 wt % to about 10 wt %.

12. The sunscreen formulation of claim 10 , wherein the active particles have a primary particle size of about 10 nm to about 200 nm.

13. The sunscreen formulation of claim 10 , wherein the emulsion stabilizer is selected from the group consisting of microcrystalline cellulose, cellulose gum, and combinations thereof.

14. The sunscreen formulation of claim 10 , wherein the skin conditioner is selected from the group consisting of C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, and combinations thereof.

15. The sunscreen formulation of claim 10 , wherein the emulsifier is selected from the group consisting of glyceryl stearate, ceteareth-20, polysorbate 80, and combinations thereof.

16. The sunscreen formulation of claim 10 , wherein the suspending agent is selected from the group consisting of polyhydroxystearic acid, methyl methacrylate crosspolymer, and combinations thereof.

17. The sunscreen formulation of claim 10 , further consisting essentially of about 0.5 wt % to about 3 wt % film former, wherein the film former is selected from the group consisting of polyurethane-2, polymethyl methacrylate, tricontanyl poly(vinyl pyrollidone) (PVP), and combinations thereof.

18. The sunscreen formulation of claim 10 , further consisting essentially of about 0.01 wt % to about 1 wt % iron oxide particles.

19. A foamable sunscreen formulation comprising:

a. about 1 wt % to about 25 wt % titanium dioxide particles having a primary particle size of about 10 nm to about 500 nm;

b. about 0.1 wt % to about 5 wt % microcrystalline cellulose and about 0.1 wt % to about 5 wt % cellulose gum;

c. about 15 wt % to about 20 wt % C 12-15 alkyl benzoate, about 0.1 wt % to about 5 wt % octyldodecyl neopentanoate, and about 0.1 wt % to about 5 wt % butyl octyl salicylate;

d. about 0.1 wt % to about 5 wt % glyceryl stearate, about 0.1 wt % to about 5 wt % ceteareth-20, and about 0.1 wt % to about 5 wt % polysorbate 80;

e. about 0.1 wt % to about 5 wt % polyhydroxystearic acid and about 0.1 wt % to about 5 wt % methyl methacrylate crosspolymer;

f. about 0.1 wt % to about 3 wt % polyurethane-2, about 0.1 wt % to about 3 wt % polymethyl methacrylate, and about 0.1 wt % to about 3 wt % tricontanyl PVP film; and

g. about 50 wt % to about 60 wt % water, wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

20. The foamable sunscreen formulation of claim 19 , further comprising about 0.01 wt % to about 1 wt % iron oxide particles.

21. A sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % active particles having a primary particle size of about 10 nm to about 500 nm;

b. about 0.1 wt % to about 10 wt % emulsion stabilizer;

c. about 0.1 wt % to about 25 wt % skin conditioner;

d. about 1 wt % to about 10 wt % emulsifier;

e. about 0.1 wt % to about 10 wt % suspending agent; and

f. the remainder water.

22. The sunscreen formulation of claim 21 , wherein the wt % of active particles is about 10 wt % to about 25 wt %.

23. The sunscreen formulation of claim 21 , wherein the active particles have a primary particle size of about 100 nm to about 500 nm.

24. The sunscreen formulation of claim 21 , wherein the emulsion stabilizer is xanthan gum.

25. The sunscreen formulation of claim 21 , wherein the skin conditioner is selected from the group consisting of octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, and combinations thereof.

26. The sunscreen formulation of claim 21 , further consisting essentially of about 0.5 wt % to about 3 wt % film former, wherein the film former is selected from the group consisting of polyurethane-2, polymethyl methacrylate, tricontanyl poly(vinyl pyrollidone) (PVP), vinyl pyrollidone/eicosene copolymer, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: MILORA, DAVID J.; FALLICK, HARRY
To: FALLIEN COSMECEUTICALS, LTD.
Reel/Frame 045221/0902 →
Continuity (5)
Continuation 15387709 · Dec 22, 2016
Continuation 14539217 · Nov 12, 2014
Continuation 13648707 · Oct 10, 2012
Provisional Application 61545848 · Oct 11, 2011
Related Publication 20180116917A1 · May 3, 2018
Cited By (1)
US 12,728,081